Mode
Text Size
Log in / Sign up

Cerebellar hypoperfusion found in most patients with anti-NF155 antibody-positive nodopathySmall study finds reduced blood flow in cerebellum of patients with rare nerve disorder

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider cerebellar hypoperfusion as a potential finding in anti-NF155 nodopathy, but recognize evidence is from a small case series.

A retrospective, single-center case series examined cerebellar perfusion in 7 male patients with anti-neurofascin-155 (NF155) antibody-positive nodopathy. The study used brain perfusion SPECT to assess cerebellar hypoperfusion, comparing findings to an age-matched database. No specific intervention or exposure was reported.

The main finding was cerebellar hypoperfusion, identified in 6 of the 7 patients (86%). Tremor was documented in all 7 patients at some point during their disease course. The analysis found no correlation between the degree of hypoperfusion and either disease duration or patient age. Effect sizes, p-values, and confidence intervals were not reported for these outcomes.

Safety and tolerability data were not reported. Key limitations include the retrospective design, very small sample size, single-center setting, and the descriptive, hypothesis-generating nature of the findings. The authors note the findings are compatible with a possible association between cerebellar perfusion abnormalities and tremor but emphasize that causality cannot be established from this study.

For clinical practice, these observations are preliminary. Larger prospective studies are warranted to validate the findings and explore any potential clinical implications. The study does not support changes to current diagnostic or treatment approaches for this rare condition.

A small, preliminary study looked at a rare nerve disorder called anti-NF155 antibody-positive nodopathy. Researchers studied seven male patients with this condition. They used a special brain scan called a perfusion SPECT to measure blood flow in the cerebellum, a part of the brain involved in movement control.

The main finding was that six out of the seven patients (86%) showed reduced blood flow, or hypoperfusion, in their cerebellum. All seven patients had experienced tremor at some point during their illness. The study did not find a link between the reduced blood flow and how long a patient had been sick or their age. The research did not report on any safety concerns related to the scans.

It is very important to be careful with these results. This was a very small study that looked back at existing patient records, not a forward-looking trial. The authors themselves say the findings are descriptive and meant to generate ideas for future research, not to prove a cause. A much larger study is needed to confirm if this reduced blood flow is a real feature of the disease and what it might mean for patients.

Readers should understand this as an early observation in a very specific group of patients. It does not change how the disease is diagnosed or treated at this time. The finding points scientists toward the cerebellum as an area to study more closely in this rare condition.

What this means for you:
Early, small study in a rare disorder; finding needs confirmation in larger research.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
IntroductionAnti–neurofascin-155 (NF155) antibody-positive nodopathy is a distinct autoimmune neuropathy characterized by sensory ataxia, tremor, and poor response to intravenous immunoglobulin (IVIg). Although classically considered a peripheral disorder, central nervous system (CNS) involvement has been suggested, but functional neuroimaging correlates remain unclear.MethodsWe retrospectively analyzed seven male patients with NF155 antibody-positive nodopathy. Clinical and electrophysiological assessments were performed, and all patients underwent brain perfusion single-photon emission computed tomography (SPECT) using 123I-IMP iodoamphetamine. Imaging data were processed using three-dimensional stereotactic surface projection (3D-SSP) and compared to an age-matched database. Cerebellar hypoperfusion was defined as regional z-scores ≤ −2.0.ResultsThe mean patient age was 39.0 ± 12.9 years, and mean disease duration was 5.0 ± 3.9 years. Tremor was documented in all patients at some point during the disease course and was predominantly postural or kinetic. Cerebellar hypoperfusion was identified in six patients (86%), involving the cerebellum bilaterally in most cases, with variable degrees of asymmetry across individuals. No correlation was found between hypoperfusion and disease duration or age.ConclusionCerebellar hypoperfusion was frequently observed in this single-center case series of anti-NF155 antibody-positive nodopathy. These findings are descriptive and hypothesis-generating, and compatible with a possible association between cerebellar perfusion abnormalities and tremor. Larger prospective studies are warranted to validate these observations and explore their clinical implications.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.